Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Will Jordan, MD"
8
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT01134510
Completed
Phase 1/2
Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
CSL Behring
ClinicalTrials.gov
NCT01134510
Completed
Phase 1/2
Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
CSL Behring
NCT01178216
Completed
Phase 1/2
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
Genentech, Inc.
ClinicalTrials.gov
NCT01178216
Completed
Phase 1/2
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitiz...
Genentech, Inc.
NCT03380377
Completed
Phase 1/2
Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant
Stanley Jordan, MD
ClinicalTrials.gov
NCT03380377
Completed
Phase 1/2
Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Tran...
Stanley Jordan, MD
NCT03380962
Active Not Recruiting
Phase 1/2
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Stanley Jordan, MD
ClinicalTrials.gov
NCT03380962
Active Not Recruiting
Phase 1/2
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Stanley Jordan, MD
NCT06813027
Active Not Recruiting
Phase 1
Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.
Abdalla Awidi Abbadi, MD
ClinicalTrials.gov
NCT06813027
Active Not Recruiting
Phase 1
Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesen...
Abdalla Awidi Abbadi, MD
NCT06825884
Active Not Recruiting
Phase 1
Use of Extracellular Vesicles (EV) for Diabetic Foot Ulcers
Abdalla Awidi Abbadi, MD
ClinicalTrials.gov
NCT06825884
Active Not Recruiting
Phase 1
Use of Extracellular Vesicles (EV) for Diabetic Foot Ulcers
Abdalla Awidi Abbadi, MD
NCT06937528
Recruiting
Phase 1
Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Abdalla Awidi Abbadi, MD
ClinicalTrials.gov
NCT06937528
Recruiting
Phase 1
Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Abdalla Awidi Abbadi, MD
NCT03917992
Completed
The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome
Ayman J Hammoudeh, MD, FACC
ClinicalTrials.gov
NCT03917992
Completed
-
The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome
Ayman J Hammoudeh, MD, FA...
Result Breakdown
Status
Completed
4 (50%)
Active, not recruiting
3 (38%)
Recruiting
1 (13%)
Phase
Phase 1/2
4 (50%)
Phase 1
3 (38%)
Not Specified
1 (13%)
Top Conditions
Antibody-mediated Rejection
2 (25%)
Kidney Transplant; Complications
2 (25%)
Transplant Glomerulopathy
2 (25%)
Show 7 more
Top Sponsors
Stanley Jordan, MD
4 (50%)
Abdalla Awidi Abbadi, MD
3 (38%)
University of Jordan
3 (38%)
Show 3 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease